BioData World Congress 

SOPHiA GENETICS is excited to be a part of the BioData World Congress 2022 annual meeting, held in-person November 8-10 in Basel, Switzerland.

Throughout the congress, our experts will be pleased to meet you at booth #99 to explore how we can help you access high-quality, real-world multimodal data in real-time.

Join us for our panel discussion on Wednesday 09 November at 12:05pm

“Hope or Hype?: The Importance of Multimodal Data Integration to Advance Precision Medicine”

Our panelists will debate the importance of combining a diversity of data modalities for the longitudinal follow-up of patients from diagnosis to treatment to outcomes, to develop a better understanding of the patient journey and to identify patient subpopulations for precision medicine.

The panel discussion will focus on:

  • The increased need for a validated platform that integrates multimodal data
  • The role of AI and real-world data in clinical practice
  • The major challenges related to applying AI in healthcare 

Panelists

David Dellamonica, MBA – Head, Digital and Innovation, Oncology Europe & Canada, AstraZeneca

Michael G. Frank, MBA – Digital Ventures Lead, Memorial Sloan Kettering Cancer Center

Jacques Cadranel, MD, Oncologist, Pneumology Service – Sorbonne Université and AP-HP Hôpital Tenon Paris

Philippe Menu, MD, PhD, MBA – Chief Medical Officer, SOPHiA GENETICS

Moderator

Peter Casasanto, MBA – Chief BioPharma Officer, SOPHiA GENETICS

SOPHiA GENETICS products are for Research Use Only and not for use in diagnostic procedures unless specified otherwise.

Event Date

November 9, 2022 – November 10, 2022

Event Type

In-person

Event Location

Europe

Areas of Interest

BioPharma

pink dots icon

Want to know more?
Get in touch with us.

Our client services team is on hand to help.
';